Rogaine launches topical foam for women

SKILLMAN, N.J. — Rogaine brand on Tuesday announced the launch of Women's Rogaine 5% Minoxidil topical aerosol, the first and only once-daily treatment approved by the Food and Drug Administration for the treatment of female pattern hair loss, according to the brand. Minoxidil is the only topical ingredient FDA-approved to help with hair regrowth.

 

The treatment works by penetrating the scalp to reactivate hair follicles and stimulate hair regrowth. It's a ideal solution for women looking for a proven solution rather than a quick cosmetic fix, the brand said. 

 

“Women with female pattern hair loss should not feel alone. Treatment options have come a long way, and the recent FDA-approval of Women’s Rogaine 5% Minoxidil topical aerosol is a major advancement in the category," said New York City dermatologist Dr. Doris Day. "Unlike cosmetic thickeners, which coat the hair and temporarily mask the issue, this innovative product when used once a day — every day —actually helps regrow hair. And, its unique, enhanced bio-delivery system is designed to break down with body heat to deposit actives on the scalp without residue to make styling that much easier.”

 

Women's Rogaine can be applied to dry or towel-dried hair and may be followed with styling products of the consumer's choice. The product also can be used on colored or chemically treated hair, but shouldn't be used on the same day of any chemical treatment to the hair; continued use of Women's Rogaine is required to maintain results.  

 

Women's Rogaine is available without a prescription for a suggested retail price of $29.99 for a two-month supply and $49.99 for a four-month supply.